Literature DB >> 22851825

Implanon: subdermal single rod contraceptive implant.

Pushpa Bhatia1, Sangita Nangia, Shivani Aggarwal, Chitra Tewari.   

Abstract

OBJECTIVES: Study was conducted to determine acceptability, efficacy, safety, return of fertility with Implanon.
METHODS: Volunteers having regular menstruation, requiring spacing formed study population. Implanon was inserted within 5 days of LMP or concurrent with MTP. Woman was asked to record bleeding pattern, side effects. Implanon duration was 3 years but Implanon was removed before, if patient wanted pregnancy/for side effects. Subjects who did not adopt family planning method after removal were followed up for return of ovulation and pregnancy.
RESULTS: 200 subjects were enrolled (160 within 5 days of LMP, 40 concurrent with MTP). 74 implanon removals were done. (16 after tenure completion, 58 for other reasons.) 16% cases discontinued implanon for polymenorrhagia, 10% for irregular bleeding, 4.5% for amenorrhea. There was no failure of implanon. 40% had return of ovulation within one month, 95.8% conceived within 12 months.
CONCLUSIONS: Implanon is safe, effective, well accepted method of contraception.

Entities:  

Keywords:  Contraceptive; Etonogestrel; Implanon

Year:  2011        PMID: 22851825      PMCID: PMC3295879          DOI: 10.1007/s13224-011-0066-z

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  10 in total

1.  [A new cause for iatrogenic lesion of the ulnar nerve at the arm: contraceptive hormonal implant. Report of two cases].

Authors:  N Osman; A Dinh; T Dubert; J N Goubier
Journal:  Chir Main       Date:  2005 Jun-Aug

2.  Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia.

Authors:  Mira Harrison-Woolrych; Richard Hill
Journal:  Contraception       Date:  2005-04       Impact factor: 3.375

3.  Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants.

Authors:  Maria Margarete Hidalgo; Claudio Lisondo; Cássia Teatin Juliato; Ximena Espejo-Arce; Ilza Monteiro; Luis Bahamondes
Journal:  Contraception       Date:  2006-03-29       Impact factor: 3.375

4.  Nerve injury caused by removal of an implantable hormonal contraceptive.

Authors:  Gottfried Wechselberger; Dolores Wolfram; Petra Pülzl; Elisabeth Soelder; Thomas Schoeller
Journal:  Am J Obstet Gynecol       Date:  2006-04-21       Impact factor: 8.661

5.  [Ectopic pregnancy with etonogestrel contraceptive implant (Implanon): first case].

Authors:  M Mansour; C Louis-Sylvestre; B-J Paniel
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2005-10

6.  Implanon failure.

Authors:  Suttha Hamontri; Wacharaporn Weerakul
Journal:  J Med Assoc Thai       Date:  2007-02

7.  Continuation rates of Implanon in the UK: data from an observational study in a clinical setting.

Authors:  Fatim Lakha; Anna F Glasier
Journal:  Contraception       Date:  2006-07-17       Impact factor: 3.375

8.  Spontaneous snapping of an Implanon in two halves in situ.

Authors:  Anjali Agrawal; Christine Robinson
Journal:  J Fam Plann Reprod Health Care       Date:  2003-10

9.  Contraceptive efficacy and side effects of Implanon.

Authors:  K Gezginc; O Balci; R Karatayli; M C Colakoglu
Journal:  Eur J Contracept Reprod Health Care       Date:  2007-12       Impact factor: 1.848

10.  Effects of the progestagen-only contraceptive implant Implanon on cardiovascular risk factors.

Authors:  Gabriele S Merki-Feld; Bruno Imthurn; Burkhardt Seifert
Journal:  Clin Endocrinol (Oxf)       Date:  2007-09-14       Impact factor: 3.478

  10 in total
  16 in total

1.  Pseudotumor Cerebri and Implanon: Is Rapid Weight Gain the Trigger?

Authors:  Nirusha Kassen; Cait-Lynn Wells; Anand Moodley
Journal:  Neuroophthalmology       Date:  2015-11-09

2.  Discontinuation of implants use and associated factors among women attending health facility clinics in Hawassa City, Southern Ethiopia, 2019; cross sectional study.

Authors:  Belay Amare Abebe; Mulu Reda Terefe
Journal:  Contracept Reprod Med       Date:  2020-10-23

3.  Discontinuation of Reversible Long-Acting Contraceptive and Associated Factors among Female Users in Health Facilities of Hawassa City, Southern Ethiopia: Cross-Sectional Study.

Authors:  Belay Amare Abebe; Nega Assefa; Bezatu Mengistie
Journal:  Open Access J Contracept       Date:  2020-08-26

4.  Early Implanon Discontinuation and Associated Factors among Implanon User Women in Debre Tabor Town, Public Health Facilities, Northwest Ethiopia, 2016.

Authors:  Mengstu Melkamu Asaye; Tewodros Syoum Nigussie; Worku Mequannt Ambaw
Journal:  Int J Reprod Med       Date:  2018-01-21

5.  Determinant of Implanon Discontinuation among Women Who Ever Used Implanon in Diguna Fango District, Wolayita Zone, Southern Ethiopia: A Community Based Case Control Study.

Authors:  Amanuel Tadesse; Mekides Kondale; Eskzyiaw Agedew; Feleke Gebremeskel; Negussie Boti; Bilcha Oumer
Journal:  Int J Reprod Med       Date:  2017-11-06

6.  Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients.

Authors:  Jianbo Wu; Yuxiu Huang; Lihong Chen; Jifen Hu; Yilu Zou
Journal:  Med Sci Monit       Date:  2018-09-01

Review 7.  Safety and Benefits of Contraceptives Implants: A Systematic Review.

Authors:  Morena Luigia Rocca; Anna Rita Palumbo; Federica Visconti; Costantino Di Carlo
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-08

8.  Permeation measurement of gestodene for some biodegradable materials using Franz diffusion cells.

Authors:  Danhua Liu; Chong Zhang; Xiaowei Zhang; Zhu Zhen; Ping Wang; Jianxin Li; Dongxu Yi; Ying Jin; Dan Yang
Journal:  Saudi Pharm J       Date:  2015-01-12       Impact factor: 4.330

Review 9.  Medically induced amenorrhea in female astronauts.

Authors:  Varsha Jain; Virginia E Wotring
Journal:  NPJ Microgravity       Date:  2016-04-21       Impact factor: 4.415

10.  Discontinuation rate of Implanon and its associated factors among women who ever used Implanon in Dale District, Southern Ethiopia.

Authors:  Abreham Nageso; Achamyelesh Gebretsadik
Journal:  BMC Womens Health       Date:  2018-11-20       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.